POMDOCTOR Ltd current report, Q3 FY2026

POMDOCTOR Ltd Form 6-K Summary

Business Context and Reporting Period

This Form 6-K filing by POMDOCTOR Ltd, a foreign private issuer, covers the month of September 2026. The report was filed on September 10, 2026, and signed by Zhenyang Shi, Chairman and Chief Executive Officer. The company is headquartered in Guangzhou, People's Republic of China.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of corporate events rather than a financial statement.

Material Changes

No material financial changes versus the prior comparable period are disclosed in this filing.

Outlook, Commentary, and Events

The primary purpose of this filing is to announce corporate activities via attached exhibits:

  • Exhibit 99.1: Press Release announcing POMDOCTOR LIMITED's participation in H.C. Wainwright's 28th Annual Global Investment Conference.
  • Exhibit 99.2: POMDOCTOR LIMITED Investor Presentation.

The filing text itself contains no specific management commentary, risk factors, or guidance beyond the announcement of these events.

Key Facts for Investor Verification

  • Verify the content of the Investor Presentation (Exhibit 99.2) for updated strategic outlooks.
  • Confirm the details of the company's participation in the H.C. Wainwright conference.
  • Note that this filing does not contain audited or unaudited financial results for the period.